ArticleJournal of intensive care2026
Proteomic identification of resistin as a NET-associated neutrophil activity marker in sepsis.
Article in Journal of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeutrophil extracellular traps (NETs) contribute to organ dysfunction in sepsis, yet clinically accessible biomarkers reflecting NET-associated pathology remain limited. We sought to identify circulating proteins associated with NET formation and evaluate their clinical relevance in sepsis.
methodsUnbiased proteomic profiling of stimulated human neutrophil supernatants and serum from murine sepsis was performed to identify proteins released during NET formation and elevated in vivo. Candidate biomarkers were selected through integration of these datasets and filtering based on cell type-specific expression profiles, followed by validation in patients with sepsis and healthy controls.
resultsIntegrative analysis identified five candidate circulating markers associated with NET formation in sepsis: cathelicidin antimicrobial peptide, lactotransferrin, neutrophil gelatinase-associated lipocalin (NGAL), resistin, and histone H4. Among these, resistin, a recently recognized neutrophil-associated protein, and NGAL demonstrated the strongest associations with sepsis-associated complications. Both markers were elevated in patients with sepsis and correlated with circulating cell-free DNA levels. In receiver operating characteristic curve analyses, resistin discriminated multiple organ failure (AUC, 0.83) and disseminated intravascular coagulation (AUC, 0.81), whereas NGAL demonstrated similarly robust performance (AUC, 0.84 and 0.79, respectively). Both markers outperformed conventional clinical parameters for discriminating sepsis-associated complications.
conclusionsThese findings identify resistin as a circulating marker associated with NET formation that captures key features of sepsis-associated immunothrombosis and organ failure and may improve assessment of disease severity and risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.